PERROTTA: "Disposizioni concernenti lo sconto minimo da applicare sui farmaci di classe C" (5944)

This legislative proposal concerns the regulation of minimum discounts that must be applied to 'Class C' medicines. These are pharmaceuticals that are not reimbursed by the state and are paid for entirely by the patient, making price controls essential for affordability. The measure primarily affects pharmaceutical companies and pharmacies. It aims to ensure that patients benefit from standardized minimum discounts, potentially lowering the out-of-pocket cost for specific non-reimbursable drugs.